Topical cosmetic peptide (acetyl octapeptide-3)
A topical cosmetic peptide marketed as a needle-free, 'Botox-like' wrinkle reducer.
| Class / type | Topical cosmetic peptide (acetyl octapeptide-3) |
|---|---|
| Category | Sexual, Skin & Aesthetic |
| Status (Jul 2026) | Research use only |
Snap-8 is claimed to interfere with the SNARE complex that mediates acetylcholine release at the neuromuscular junction, theoretically reducing the muscle contractions that cause expression lines. Evidence for meaningful skin penetration is limited.
Used in skincare/cosmetic formulations (creams, serums) to reduce the appearance of fine lines and expression wrinkles.
Non-invasive topical alternative marketed for expression lines; generally well tolerated on skin; no injections.
Weak independent clinical evidence; effects are modest and cosmetic at best; potential mild skin irritation; marketing often overstates 'Botox-like' results.
Skincare users report subtle smoothing at most and generally view it as far milder than injectable neurotoxins.
NOT FDA-approved as a drug; used as a cosmetic ingredient, and anti-wrinkle 'drug-like' claims are not FDA-evaluated.
Plain-language updates on new research and the shifting rules. No hype, unsubscribe anytime.